“Accelerated by the good fortune of our VIDA Intelligence Portal, we now have a developing network of sites with the skills, generation and workflows critical to the good fortune of breathing trials and studies,” said Sandra Stapleton, COO of VIDA. “Through our VIDA Intelligence Portal, sponsors now have access to sites and a greater perception of testing activities in their projects. “
“By combining our developing network with the strength of our vast amount of data, we can offer really exciting facilities to sponsors,” Stapleton said. “Virtual control arms and theme matching facilities are two examples of what is imaginable with VIDA assets. These and other facilities are designed to dramatically increase the power of trials so that healing inventions can succeed in patients faster. “
VIDA presents its VIDA Intelligence portal at the 2022 American Thoracic Society (ATS) International Conference at booth #1427, with new AI-enabled biomarker services.
About VIDA Diagnostics, Inc.
VIDA is a precision lung fitness company, accelerating treatments for patients through AI-powered pulmonary intelligence. VIDA DiscoverySM enables more effective breathing clinical trials by offering more accurate quantitative endpoints, AI-driven knowledge quality controls, on-site training, and much more. more to help biopharmaceutical sponsors save millions in drug progression costs. VIDA Insights™ enables clinicians to better manage patients with or at risk for chronic obstructive pulmonary disease (COPD), interstitial lung disease, asthma, emphysema, lung cancer, and COVID-19. VIDA software is FDA approved, CE marked, fitness canada clearance, TGA registration, and PMDA certified for clinical use in the United States, the European Economic Area, Canada, Australia, and Japan. Learn more on https://vidalung. ai. Suivez @vidalung on Twitter and LinkedIn.
SOURCE VIDA Diagnostics, Inc.